Julie Vermeersch
Overview
Julie Vermeersch is an associate in Crowell & Moring’s Brussels office and a member of the Intellectual Property Group. She focuses primarily on contentious and noncontentious issues affecting the life sciences sector. She also assists clients with other IP concerns, e.g., relating to artificial intelligence (AI) and the General Data Protection Regulation (GDPR).
Career & Education
- Free University of Brussels (Université Libre de Bruxelles), Master of Law, 2025
- Free University of Brussels (Université Libre de Bruxelles), Bachelor of law, 2022
- Dutch
- French
- English
Julie's Insights
Client Alert | 7 min read | 12.15.25
The New EU “Pharma Package:” EU Reaches Landmark Deal on Pharma Package
On December 11, 2025, the Council of the European Union and the European Parliament reached provisional agreement on the long-awaited “Pharma Package,” (see the announcement here). The Pharma Package is a comprehensive and major overhaul of the EU legislative framework for pharmaceuticals, which replaces the more than 20-year-old Directive 2001/83 and Regulation 726/2004 and incorporates (and updates) the separate regulations on orphan and pediatric medicines (Regulations 141/2000 and 1901/2006 respectively).
Client Alert | 11 min read | 12.01.25
Insights
Julie's Insights
Client Alert | 7 min read | 12.15.25
The New EU “Pharma Package:” EU Reaches Landmark Deal on Pharma Package
On December 11, 2025, the Council of the European Union and the European Parliament reached provisional agreement on the long-awaited “Pharma Package,” (see the announcement here). The Pharma Package is a comprehensive and major overhaul of the EU legislative framework for pharmaceuticals, which replaces the more than 20-year-old Directive 2001/83 and Regulation 726/2004 and incorporates (and updates) the separate regulations on orphan and pediatric medicines (Regulations 141/2000 and 1901/2006 respectively).
Client Alert | 11 min read | 12.01.25
